Fruk Lab

Online now! ✨Hartono et al develop a nanoprobe to enable urine-based detection of senescence burden, applicable to therapy-induced senescence in lung cancer and to lung fibrosis @danielMuozEspn1 @FrukLab @EarlyCancerCam @cebcambridge @Cambridge_Uni

Read more: 📄Research paper: nature.com/articles/s4358… 📰 News & Views: nature.com/articles/s4358…

This work was made possible thanks to the generous support of our funders: @CR_UK, @The_MRC, @EPSRC, @CambridgeBRC, @CRUKCamCentre, @CRUKCamThoracic, the WD Armstrong Studentship, the Darley/Sands Downing College Fellowship, and additional supporters.

Excited to share our latest work out today in @NatureAging from a collaboration between our lab @FrukLab and @MunozEspin_Lab! @EarlyCancerCam @cebcambridge 🔗nature.com/articles/s4358…

Thrilled to share the latest paper from a collaboration between our lab @MunozEspin_Lab @EarlyCancerCam and @FrukLab, and published today in @NatureAging

Congratulations to Dr Matthew! 🎉 He successfully defended his PhD on hollow-core photonic crystal fibres for studying flavin-based photocatalysts. We’re so proud of his work and excited to see his impact as a postdoc at @EarlyCancerCam @Cambridge_Uni!

The clay's the thing! 🪣 Research conducted at CEB has developed a brand new material from clay and vitamin B2 that could clean-up pollutants using nothing but sunlight. More: ceb.cam.ac.uk/news/flaponite 🧪⚙️🌱🔋 #ChemicalEngineering #Biotechnology #CambridgeUniversity @FrukLab

🌟Out now & on the cover of @CatalysisSciTec ! Meet Flaponite – our recyclable, flavin-based photocatalyst using LAPONITE clay as a green support. Enhanced activity, easy recovery, and inspired by nature! Congrats Matthew & the whole team!👏 🔗doi.org/10.1039/D5CY00…

We also offer a new perspective and suggest strategies for moving forward 🚀

🎯 Antigen depletion by targeted nanoparticles; they can undermine their own targets

💊 Dosing complexities that go well beyond what we see with small molecules

In this article, we discuss three key challenges holding back the clinical translation of targeted nanomedicine: 👤 Pharmacokinetics of nanoparticle antibody conjugates; turns out they are not as straightforward as it seems

If you're interested in targeted nanomedicine (and open to some opinions), check out our latest piece: "Reimagining drug nanocarriers: clinical realities and smarter strategies for targeted drug delivery" pubs.rsc.org/en/content/art…

We're delighted to announce the 2025 Danckwerts-Pergamon prize has been awarded to Muhammad Hartono for his innovative work on non-invasive lung cancer screening. Read more on our website: ceb.cam.ac.uk/news/danckwert… 🧪⚙️🌱🔋 #ChemicalEngineering #Biotechnology #Cambridge

Check out a new review article published in collaboration with the Itzhaki lab! Read the full thread below 🧵👇